` 302440 (SK Bioscience Co Ltd) vs KOSPI 200 Comparison - Alpha Spread

302440
vs
KOSPI 200

Over the past 12 months, has underperformed KOSPI 200, delivering a return of -35% compared to the KOSPI 200's 8% drop.

Stocks Performance
302440 vs KOSPI 200

Loading

Performance Gap
302440 vs KOSPI 200

Loading
302440
KOSPI 200
Difference

Performance By Year
302440 vs KOSPI 200

Loading
302440
KOSPI 200
Add Stock

Competitors Performance
SK Bioscience Co Ltd vs Peers

KOSPI 200
302440
ABBV
AMGN
GILD
VRTX
Add Stock

SK Bioscience Co Ltd
Glance View

Market Cap
3.2T KRW
Industry
Biotechnology

SK Bioscience Co Ltd., a remarkable enterprise carved out of the South Korean corporate landscape, operates at the dynamic intersection of biotechnology and pharmaceuticals. A part of the larger SK Group, one of Korea's leading conglomerates, the company was officially established in 2018 from SK Chemicals' life sciences division. Its primary focus is on developing and manufacturing vaccines, serving both public health needs locally and globally. The company has swiftly gained prominence for its role in the COVID-19 pandemic, particularly with the production of vaccines in collaboration with significant players such as AstraZeneca and Novavax. This strategic engagement loop has positioned SK Bioscience not only as a critical player in health crises management but also as a pivotal contributor to global health security. At the heart of SK Bioscience's business model is its ability to leverage cutting-edge research and robust manufacturing capabilities. The firm generates revenue through various channels, including product sales of its vaccines and other pharmaceuticals, contract manufacturing services, and partnerships with global entities, allowing it a diversified income stream. Its adeptness in innovation, underpinned by a strong R&D framework, ensures a steady development pipeline, supporting long-term growth ambitions. Through these strategic activities, SK Bioscience aligns itself with the SK Group’s broader commitment to social value and environmental, social, and governance (ESG) principles, fortifying its reputation as a company that not only seeks financial success but also endeavors to wield a positive global impact.

Intrinsic Value
14 429.17 KRW
Overvaluation 64%
Intrinsic Value
Price
Back to Top